Internal Medicine · Houston, TX
NPI
1396987756
Since 2009
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
520 services
Medicare patients, 2024
189
Average age 70
Drug cost, 2024
$1.4M
424 prescriptions
Company payments, 2024
$2,556
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria A Zarzour was code 99215 (office e&m - established), 141 times for 65 patients. In total Maria A Zarzour billed 520 services in 18 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 141 | 65 | $109.07 | $15K |
| 99214 Office E&M - Established | Facility | 122 | 73 | $71.60 | $8,735 |
| 99213 Office E&M - Established | Facility | 63 | 47 | $48.74 | $3,071 |
| 99232 Hospital E&M - Subsequent | Facility | 33 | 15 | $58.62 | $1,934 |
| 99205 Office E&M - New | Facility | 30 | 30 | $145.09 | $4,353 |
| 99233 Hospital E&M - Subsequent | Facility | 26 | 16 | $94.02 | $2,444 |
| 99441 Telephone Services | Office | 20 | 11 | $41.99 | $840 |
| 99214 Office E&M - Established | Office | 18 | 13 | $101.67 | $1,830 |
| 99223 Hospital E&M - Initial | Facility | 16 | 16 | $127.01 | $2,032 |
By year: 2022 $43K for 485 services; 2023 $47K for 547 services; 2024 $45K for 520 services.
Medicare prescription drug claims, 2024
In 2024, the drug Maria A Zarzour prescribed most often to Medicare patients was Imatinib Mesylate, with 196 prescriptions and refills. In total Maria A Zarzour wrote 424 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 196 | 206 | 22 | $109K |
| Cabometyx Cabozantinib S-Malate | 29 | 29 | Under 11 | $714K |
| Prochlorperazine Maleate Generic | 21 | 21 | 18 | $322 |
| Ondansetron Hcl Generic | 20 | 20 | 13 | $105 |
| Votrient Pazopanib Hcl | 16 | 16 | Under 11 | $276K |
| Loperamide Loperamide Hcl | 14 | 14 | Under 11 | $219 |
| Sorafenib Sorafenib Tosylate | 12 | 12 | Under 11 | $41K |
Brand drugs: 62 claims; generic drugs: 362 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Maria A Zarzour $2,556 ($2,556 in general payments such as food, travel and fees) from 2 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $2,539.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 9 | $2,539 |
| Argon Medical Devices, Inc. | 1 | $16.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.